Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug;14(4):721-732.
doi: 10.1007/s41999-023-00821-x. Epub 2023 Jul 7.

Therapeutic dilemmas: cognitive enhancers and risk of falling in older adults-a clinical review

Affiliations
Review

Therapeutic dilemmas: cognitive enhancers and risk of falling in older adults-a clinical review

Gabbie E Portlock et al. Eur Geriatr Med. 2023 Aug.

Abstract

Purpose: Cognitive enhancers are the primary pharmacological therapy prescribed to those with dementia, comprising of memantine and the acetylcholinesterase inhibitors (AChEIs). The long-term cognitive and behavioural benefits of these medications, as well as their potential contribution to falls is currently debated, with recent Delphi studies being unable to reach consensus on whether these medications should be deprescribed. In this narrative clinical review, as part of a series on deprescribing in people at risk of falls, we explore the potential falls-related side effects experienced in people taking cognitive enhancers, alongside situations where deprescribing may be appropriate.

Methods: We undertook a literature search of PubMed and Google Scholar, using terms capturing falls and cognitive enhancers, as well as consulting the British National Formulary and published Summary of Medicinal Product Characteristics. These searches informed the subsequent clinical review.

Results: Cognitive enhancers should be subject to regular review, including confirmation of appropriate treatment indication, and occurrence of side effects in the context of falls. AChEIs, in particular, are associated with a broad range of side effects that can contribute to increased falls risk. These include bradycardia, syncope and neuromuscular effects. Where these have been identified, deprescribing should be considered, as well as alternative treatment options. Deprescribing studies have shown mixed results, likely due to considerable methodological heterogeneity. Several suggested guidelines exist to aid deprescribing decisions, many of which are highlighted in this review.

Conclusions: The use of cognitive enhancers should be regularly reviewed and decisions to deprescribe made on a case-by-case basis, considering both the risks and benefits of stopping these medications.

Keywords: Cognitive enhancers; Dementia; Deprescribing; Falls.

PubMed Disclaimer

Conflict of interest statement

GEP, MDS, and EPP have no relevant financial or non-financial interests to disclose. TW is Research and Medical Director of The Research Institute for the Care of Older People (RICE), which runs a mixture of commercial and non-commercial research activity. Commercial research projects run in the Institute have been funded by: Roche, Biogen, Janssen, AC Immune, Novo Nordisk, and Julius Clinical.

Similar articles

Cited by

References

    1. World Health Organisation (WHO). Falls—fact sheet 2021. https://www.who.int/news-room/fact-sheets/detail/falls. Accessed 11 Dec 2022
    1. Dionyssiotis Y. Analyzing the problem of falls among older people. Int J Gen Med. 2012;5:805–813. doi: 10.2147/IJGM.S32651. - DOI - PMC - PubMed
    1. Murphy J, Isaacs B. The post-fall syndrome. Gerontology. 1982;28:265–270. doi: 10.1159/000212543. - DOI - PubMed
    1. Schoene D, Heller C, Aung YN, Sieber CC, Kemmler W, Freiberger E. A systematic review on the influence of fear of falling on quality of life in older people: is there a role for falls? Clin Interv Aging. 2019;14:701–719. doi: 10.2147/CIA.S197857. - DOI - PMC - PubMed
    1. Payette MC, Bélanger C, Léveillé V, Grenier S. Fall-related psychological concerns and anxiety among community-dwelling older adults: systematic review and meta-analysis. PLoS ONE. 2016;11:e0152848. doi: 10.1371/JOURNAL.PONE.0152848. - DOI - PMC - PubMed

Publication types

MeSH terms